Román Freixa‐Pamias

2024 ESC Guidelines for the management of chronic coronary syndromes

Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas et al. · European Heart Journal · 2024 · 2.4K citations · Full text

Medicine, Cardiology, Internal Medicine +14

Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

Xavier Rosselló, Sergio Raposeiras‐Roubín, Roberto Latini et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2021 · 65 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

Alberto Cordero, María Rosa Fernández Olmo, Gustavo Aníbal Cortez Quiroga et al. · Journal of Cardiovascular Pharmacology · 2022 · 30 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Radiofrequency Ablation of a Posteroseptal Atrioventricular Accessory Pathway in a Left‐Sided Tricuspid Ring with Ebsteinlike Anomaly in a Patient with Congenitally Corrected Transposition of the Great Arteries

Josép Brugada, Valentí Valls, Román Freixa‐Pamias et al. · Pacing and Clinical Electrophysiology · 2000 · 29 citations

Medicine, Cardiology, Surgery +11

Effect of <scp>PCSK9</scp> inhibitors on remnant cholesterol and lipid residual risk: The <scp>LIPID‐REAL</scp> registry

Alberto Cordero, Ma Rosa Fernández del Olmo, Gustavo Aníbal Cortez Quiroga et al. · European Journal of Clinical Investigation · 2022 · 23 citations

Life Sciences, Pharmacology, Pharmacotherapy +17